Health ❯ Healthcare

Research and Development

Clinical Trials Clinical Research Pharmaceuticals Drug Development Innovative Therapies Biotechnology Medical Innovations Clinical Studies Innovative Treatments Drug Mechanisms

3 ARTICLES

2d ago

Penn Launches First U.S. Pilot Trial of Conformal FLASH Proton Therapy

This Phase I study tests whether five ultra‑fast treatments can spare healthy tissue by shortening the time patients spend receiving radiation for recurrent head and neck cancer.

10 ARTICLES

3d ago

Sionna Halts SION-719 After Mid-Stage Cystic Fibrosis Trial Misses Key Biomarker

6 ARTICLES

4w ago

Tampa General Announces EMS-Driven Drone Pilot to Deliver Whole Blood

6 ARTICLES

4w ago

Novo Nordisk’s Ziltivekimab Lowers Inflammation but Fails to Reduce Major Heart Events

12 ARTICLES

last mo.

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

3 ARTICLES

last mo.

Pfizer’s Oral Drug Shows Strong Phase 3 Results in Nonsegmental Vitiligo

3 ARTICLES

last mo.

Spero Licenses Innovent’s Anti‑CD40L Antibody Outside Greater China in Up to $1.1 Billion Deal

3 ARTICLES

last mo.

Silo Pharma Raises $4 Million in Private Placement as Shares Fall 28%

3 ARTICLES

last mo.

Ipsen Says Dysport Met Phase 3 Endpoints for Episodic and Chronic Migraine

6 ARTICLES

2mo ago

NITI Aayog Unveils Roadmap to Globalize Ayurveda by 2047

6 ARTICLES

2mo ago

Duke Scientists Grow Retinal Blood-Vessel Cells From Human iPSCs

6 ARTICLES

2mo ago

NICE Approves Teplizumab for Early Type 1 Diabetes on the NHS

3 ARTICLES

2mo ago

NHS CAR‑T Puts Most Trial Lupus Patients Into Remission

3 ARTICLES

3mo ago

King's College Hospital Opens UK's First Rooftop Critical Care Garden

3 ARTICLES

3mo ago

Research and Development

Penn Launches First U.S. Pilot Trial of Conformal FLASH Proton Therapy

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

Moderna Prices $2.6 Billion Zero‑Coupon Convertible Notes With Capped Calls

FDA Approves Rasonque, an Oral KRAS Inhibitor, for Metastatic Pancreatic Cancer

AstraZeneca Stops Phase III Volrustomig Lung Cancer Trial

INVO Fertility Shares Surge After Surprise Positive Q2 Earnings

Sionna Halts SION-719 After Mid-Stage Cystic Fibrosis Trial Misses Key Biomarker

Tampa General Announces EMS-Driven Drone Pilot to Deliver Whole Blood

Novo Nordisk’s Ziltivekimab Lowers Inflammation but Fails to Reduce Major Heart Events

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

Never miss stories about

Research and Development

Pfizer’s Oral Drug Shows Strong Phase 3 Results in Nonsegmental Vitiligo

Spero Licenses Innovent’s Anti‑CD40L Antibody Outside Greater China in Up to $1.1 Billion Deal

Silo Pharma Raises $4 Million in Private Placement as Shares Fall 28%

Ipsen Says Dysport Met Phase 3 Endpoints for Episodic and Chronic Migraine

NITI Aayog Unveils Roadmap to Globalize Ayurveda by 2047

Duke Scientists Grow Retinal Blood-Vessel Cells From Human iPSCs

NICE Approves Teplizumab for Early Type 1 Diabetes on the NHS

NHS CAR‑T Puts Most Trial Lupus Patients Into Remission

King's College Hospital Opens UK's First Rooftop Critical Care Garden

Ipsen Says First Head-to-Head Trial Finds Dysport Matches Botox on Safety and Lasts Slightly Longer

Never miss stories about

Research and Development